Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. | EMBO J | 2001 | 6.85 |
2 | Cross talk between stimulated NF-kappaB and the tumor suppressor p53. | Oncogene | 2010 | 1.38 |
3 | Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradation. | Leukemia | 2010 | 0.99 |
4 | Inhibitors of HDACs--effective drugs against cancer? | Curr Cancer Drug Targets | 2010 | 0.98 |
5 | SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation. | Oncogene | 2012 | 0.89 |